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Abstract
Several methods for the preparation of sterically stabilized immunoliposomes (SIL) have recently been described. This
report examines an established method for coupling anti-CD34 My10 mAb to poly(ethylene glycol)-liposomes (PEG-
liposomes) containing the anchor pyridyldithiopropionylamino-PEG-phosphatidylethanolamine (PDP-PEG-PE) via a
cleavable disulfide bond. Efficient attachment of pyridyldithio-derivatized mAb took place (equivalent to coupling ca. 70% of
total input protein) at 2 mol percent of the functionalized PEG-lipid. The My10-SIL bound specifically to CD34+ cells
(human leukemic KG-1a and hematopoietic progenitor cells) and the extent of binding was a function of liposomal lipid
concentration, the mAb density in the liposome surface and the CD34 cell expression. In mixtures with CD34- cells (CHO or
Jurkat), CD34+KG-1a cells were determined by flow cytometry at percentages (1^4%) similar to those reported in clinical
samples (such as cord blood, mobilized peripheral blood and bone marrow) using a direct immunostaining with My10-SIL.
The disulfide bond was stable in cell culture medium (10% of fetal calf serum) during 8 h and cell-bound SIL can be released
from cells by treatment with dithiothreitol as reducing agent under mild conditions (1 h of incubation with 50 mM DTT at
20‡C). SIL binding and subsequent dithiothreitol treatment did not influence the cell viability. Our approach should
contribute to the development of targetable liposomal vehicles to CD34+ cells for use in ex vivo conditions as sorting of
hematopoietic stem cells. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
The description of sterically stabilized liposomes
(SL) containing lipid derivatives of poly(ethylene gly-
col) (PEG) has meant increased opportunities for
speci¢c, ligand-mediated, targeting of liposomes to
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(ethylene glycol) ; mPEG-PE, methoxy poly(ethylene glycol)-phosphatidylethanolamine; PDP-PEG-PE, pyridyldithiopropionylamino-
poly(ethylene glycol)-phospahtidylethanolamine; SPDP, N-succinimidyl-3-(2-pyridyldithio)propionate; P, polydispersity index; DTT,
dithiothreitol ; CF, carboxy£uorescein; MFI, mean £uorescence intensity; GAM, F(ab)2 fragment goat-anti-mouse IgG; TL, total lipid
* Corresponding author. Fax: +34-93-4021219; E-mail : domingo@sun.bq.ub.es
BBAMEM 77962 5-12-00
Biochimica et Biophysica Acta 1509 (2000) 299^310
www.elsevier.com/locate/bba
speci¢c sites [1]. The in vivo properties of SL, which
include low RES uptake, prolonged circulation life-
times and also accumulation at pathological sites,
have been widely reviewed [1]. Also in in vitro stud-
ies, the presence of PEG on the liposome surface was
shown to provide an e¡ective method to improve
liposome stability in a biological milieu [2], related
to the inhibition of serum protein adsorption [3,4]
and cell adhesion [3].
The attachment of monoclonal antibody (mAb) to
the surface of SL is one of the most e¡ective ways of
targeting antigen expressing cells [5,6] and, some-
times, speci¢c uptake by target cells is observed [7].
This approach is being applied principally to im-
prove the therapeutic e⁄cacy of anticancer drugs
against neoplastic diseases [5,8], although the ap-
proach is not limited to the treatment of cancers
[2]. Several approaches to the preparation of steri-
cally stabilized immunoliposomes (SIL) have recently
been developed [4,5,9,10]. The interference of lipo-
some-grafted mPEG chains, observed with both cou-
pling of ligands to the lipid bilayer and with the
interaction of these ligands with the intended biolog-
ical targets, could be minimized by attaching the
protein to the distal end of the PEG chains
[4,5,9,10]. Moreover, the presence of PEG coat im-
proves immunospeci¢c binding to target cells in vi-
tro, probably by reducing nonspeci¢c binding of
SIL to irrelevant cells [11]. Experiments in vitro
have shown that the speci¢c binding of SIL to target
cells increased both with the lipid concentration
and the mAb density on the liposome surface [4,5,
9,10].
Today, the covalent methods described for cou-
pling mAb to the PEG terminus use linkage chemis-
try to obtain in vivo stable antibody-PEG linkage,
e.g., thioether [4,5], amide [10] or hydrazone [8,9]
attachments. For ex vivo applications such as immu-
nomagnetic cell sorting [12], the ability to remove
attached liposomes to cells after treatment might be
useful. This can be achieved by introducing a cleav-
able linkage between the polymer chain and the
mAb.
In the present study, we describe the preparation
of SIL containing a thiolytically cleavable bond be-
tween the mAb and the PEG based on the use of
the heterobifunctional N-succinimidyl-3-(2-pyridyldi-
thio)propionate (SPDP) reagent developed originally
for the preparation of classical immunoliposomes
[13]. The My10 mAb, speci¢c to the human CD34
antigen, was used in this study and KG-1a cells were
used as target cells as they are well characterized for
their CD34 expression [4,13]. The CD34 antigen was
the target of selection because it is selectively ex-
pressed by only 1^4% of normal bone marrow cells,
including the earliest assayable hematopoietic pro-
genitors [14]. Moreover, the CD34 lack of expression
by mature hematopoietic cells makes the antigen a
suitable candidate target molecule for isolating hem-
atopoietic stem cells as a part of autotransplantation
procedures [15]. The e¡ect of experimental variables
on the SIL preparation and on the targeting ability
in vitro was examined. On the basis of these studies,
we present a modi¢ed design of SIL for ex vivo ap-
plications that exhibits high levels of selective target-
ing and that allows the rapid chemical release of the
liposomes from the target cells while guaranteeing
cell viability [16].
2. Experimental procedures
2.1. Materials
Egg phosphatidylcholine (PC), egg phosphatidyl-
ethanolamine (PE) and methoxy PEG (2000) phos-
phatidylethanolamine (mPEG-PE) were obtained
from Avanti Polar Lipids Inc. Cholesterol (Chol),
£uorescein isothiocyanate, isomer I (FITC), SPDP
and dithiothreitol (DTT) were obtained from Sigma
Chemical Co. (St. Louis, MO, USA). tBoc-NH-
PEG(3400)-CO2-NHS was obtained from Shearwater
Polymers Inc. 5(6)-Carboxy£uorescein (CF), ob-
tained from Eastman-Kodak, was puri¢ed as de-
scribed elsewhere [17].
My-10 clone, human leukemic KG-1a, human T-
lymphoma Jurkat and Chinese hamster ovary cells
(CHO) were obtained from the ATCC (American
Type Culture Collection, Rockville, MD, USA).
Cells were grown as a suspension culture in RPMI-
1640 medium (Gibco), supplemented with 10% (v/v)
heat-inactivated fetal calf serum, 2 mM L-glutamine,
1 mM sodium pyruvate, 100 units of penicillin and
100 Wg/ml streptomycin (Biological Industries, Kib-
butz Beth Haemek, Israel), at 37‡C in a humidi¢ed
atmosphere of 5% CO2 and split 1:2 every 2 days.
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Mouse mAb HPCA2 (anti CD34 FITC-IgG1, clone
8G12) and isotype-matched control IgG1 (clone
MOPC-21) were obtained from Becton Dickinson
(San Jose, CA, USA).
2.2. Synthesis of pyridyldithiopropionylamino-
poly(ethylene glycol)-phospahtidylethanolamine
(PDP-PEG-PE)
PDP-PEG-PE was prepared as described in [4].
Brie£y, t-Boc-NH-PEG(3400)-CO2-NHS (70 mg) dis-
solved in CHCl3 (0.5 ml) was reacted with PE (15.3
mg), in the presence of TEA (16 Wl), for 2 h at room
temperature. Afterwards, the excess of PE was re-
moved by precipitation in acetonitrile. The resulting
product was incubated for 20 min at room temper-
ature with TFA (40% v/v) to eliminate the t-Boc
group. Next, the amino-PEG-PE obtained was
coupled to SPDP (SPDP/lipid = 1.2) by incubation
for 5 h at room temperature in the presence of
TEA. The ¢nal product was crystallized in ether
and obtained with a weight yield of 70%. The purity
of the product was con¢rmed by TLC, obtaining a
single negative ninhydrin and phosphate-positive
spot. The purity determined by the PDP/lipid ratio
was s 90%. PDP groups were determined by the
release of 2-thiopyridone upon the addition of excess
DTT [18] and phospholipid was measured by phos-
phorus assay [19].
2.3. Preparation of antibodies
The mAb (2 mg/ml) was labelled with FITC as
described elsewhere [13]. Brie£y 50 Wg FITC were
incubated with 1 mg mAb in 0.25 M carbonate/bi-
carbonate bu¡er (NaCl 0.1 M, pH = 9.1) overnight at
4‡C, with gentle stirring. The reaction mixture was
light-protected. The unreacted dye was removed by
gel ¢ltration over Sephadex G-50 spin columns. The
FITC-mAb was eluted in the void volume. The con-
jugation ratio (number of FITC molecules per mAb)
was determined by measuring the optical density at
280 and 495 nm, obtaining six FITC molecules/mAb.
In order to bind the mAb or FITC-mAb to the
liposomes, the mAb (2 mg/ml in PBS) was conju-
gated with the heterobifunctional reagent, SPDP
(SPDP/mAb 15/1 molar ratio). Excess SPDP was re-
moved by Sephadex G-50 spin column. As estimated
spectrophotometrically [18], there were four PDP res-
idues per mAb molecule.
2.4. Liposome preparation
Liposomes composed of PC/Chol 2/1 and 5 mol
percent of PEG derivatives were prepared by hydrat-
ing dry lipid ¢lms in PBS pH = 7.4 or CF 50 mM in
PBS. When indicated, rhodamine-PE (Rho-PE) was
incorporated at an amount of 0.1 mol percent of
total lipid (TL). The resulting multilamellar prepara-
tions were then passed through polycarbonate mem-
brane ¢lters with 0.4, 0.2 and 0.1 Wm pore size (man-
ufactured by Nucleopore Corp.) in an extrusion
device (Lipex Biomembranes Corp.) to obtain unila-
mellar vesicles of approximately 100 nm in diameter
[4]. The prepared vesicles were sized by dynamic laser
light scattering using a PCS41 optic unit (Malvern
Autosizer IIC). The system reports a polydispersity
index (P) as a measure of particle size distribution.
The complete incorporation of PDP-PEG-PE at a
concentration up to 5 mol percent was shown by
the 100% release of 2-thiopyridone from liposomes
following reduction of PDP with DTT as determined
spectrophotometrically [4,13].
2.5. Preparation of SIL
Two methods were used to bind the mAb to the
terminus of PEG on SL:
2.5.1. Method 1
Liposomes containing PDP-PEG-PE were thio-
lated by incubation with DTT 50 mM for 30 min
at 4‡C. DTT was separated by passing the liposomes
over a Sephadex G-50 column eluted with PBS
pH = 7.4. The thiolated liposomes (1.2 Wmol) were
incubated for 24 h at room temperature with varying
amounts of FITC-mAb-PDP or mAb-PDP at a ¢nal
TL concentration around 3.6 mM. To block free
thiols on the liposome surface, the suspension was
incubated with iodoacetamide (4 mM) for 2 h at
room temperature [4], since these groups can increase
nonspeci¢c interactions [5,6]. Excess iodoacetamide
was removed with unbound mAb.
2.5.2. Method 2
Thiolated mAb (mAb-SH) was obtained reducing
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the mAb-PDP with DTT 50 mM at pH = 4.5. Excess
DTT was removed using a Sephadex G-50 spin col-
umn. The protein with reduced thiols must be kept in
a N2 atmosphere and used immediately. Freshly pre-
pared mAb-SH were mixed with liposomes contain-
ing the coupling lipid, PDP-PEG-PE, at similar con-
centrations to those in method 1, and were incubated
for 24 h at room temperature, with stirring.
In both methods, the free mAb was removed by
chromatography on Sepharose 4B. SIL were eluted
in the ¢rst fractions as measured by phospholipid
[20] and FITC £uorescence determinations [4,13].
2.6. SIL characterization
The amount of mAb coupled to liposomes was
calculated using FITC-mAb-SIL. The lipid concen-
tration was quanti¢ed by phospholipid determination
[20]. The protein was determined by FITC £uores-
cence in comparison to a standard curve [13]. The
number of vesicles was calculated as previously de-
scribed [21] and was estimated at 2.74U1012 vesicles/
Wmol TL.
The stability of SIL was determined by measuring
the release of an entrapped dye (CF). Fluorescence
intensity (Vex = 492; Vem = 520), before and after lipo-
some lysis with 5% Triton X-100, was measured with
a Kontron SFM25 spectro£uorimeter [22].
2.7. In vitro cell binding studies
The binding of SIL entrapping CF to cells was
analyzed by £ow cytometry using a direct immuno-
staining assay [4,13]. As CD34+ cells, we used the
KG-1a cell line and human hematopoietic progenitor
cells puri¢ed by magnetic cell sorting from apheresis
of a donor patient. In both experiments, exponen-
tially growing cells (106 cell/ml), resuspended in
PBS supplemented with 1% bovine serum albumin
(PBA), were incubated with SIL for 30 min at 4‡C.
Afterwards, they were rinsed twice in PBA and re-
suspended at the ¢nal concentration of 106 cells/ml.
As a control, cells incubated with SL entrapping CF
were used. In the assay with cell mixtures, the per-
centage of CD34+ cells was determined by direct im-
munostaining assay using SIL entrapping CF (100^
200 WM) and the mAb HPCA-2 labelled with FITC
(2 Wg/ml), and by indirect immunoassay using the
My10 mAb (2 Wg/ml) and a secondary Ab F(ab)2
fragment goat-anti-mouse IgG (GAM-FITC) (5 Wg/
ml). The analyses were performed using an EPICS
XL-MCL £ow cytometer (IZASA-Coulter, Spain),
equipped with an argon ion laser tuned at 488 nm
as excitation source. The green £uorescence (CF) was
measured through a BP 525 nm ¢lter. All £uores-
cence measurements were collected as a logarithmic
signal. Sample acquisition was stopped when the
90LS-£uorescence histogram 10 000-gated events
were achieved. All data were stored as listmode hard-
copies and analyzed with the EPICS XL-MCL Work-
station Software version 2.0.
The binding of SIL to KG-1a cells was also cor-
roborated by spectro£uorimetry. SIL (200 WM) were
incubated with cells (106 cells/ml) for 30 min at 4‡C.
The cells were washed three times with PBA and the
cell-associated £uorescence was measured in the pres-
ence of a 5% Triton X-100 on a Kontron SF25 £uo-
rimeter with excitation wavelength set at 492 nm and
emission at 520 nm.
2.8. Cleavage of SIL bound to cells
The SIL bound to the cells were removed by ad-
dition of 20 or 50 mM DTT (from 1 M stock solu-
tion) and the suspension incubated for 30 min or 1 h
at di¡erent temperatures. After treatment, the cells
were rinsed three times in cold PBA to remove the
DTT and then analyzed.
2.9. Viability assay
The viable cells were enumerated in a hemocytom-
eter on the basis of trypan blue dye exclusion. Un-
treated cells, maintained in the same conditions, were
taken as a control. The viability was also determined
by £ow cytometry using double labelling with propi-
dium iodide (PI) and £uorescein diacetate (FDA).
The cells were washed and resuspended in 50 Wl of
PBS. Afterwards, l0 Wl of PI (20 Wg/ml) and 10 Wl of
FDA (1 Wg/ml) were added to the cell suspension,
which was incubated for 30 min at 4‡C. Following
incubation, the green (FDA) and red £uorescence
(PI) cells were analyzed at 488 nm excitation and
£uorescence signals were collected at 525 nm and
620 nm, respectively.
Cell cycle analysis was also performed using £ow
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cytometry. After 24 h of incubation at 37‡C, the cells
were rinsed three times with cold PBA and permea-
bilized with MeOH (70%) at 320‡C for 15 min. Cells
were washed with cold PBA and resuspended in a
PBS solution containing 0.5% RNase, 20 Wg/ml PI
and incubated for 30 min at room temperature prior
to analysis.
3. Results and discussion
3.1. Conjugation of My10 mAb to SL
We have previously described the preparation of
anti-CD34 SIL with a combination of PEG-PE de-
rivatives with short and long PEG chains, which im-
prove SIL preparation e⁄ciencies and targeting [4].
Sterically stabilized unilamellar liposomes, composed
of PC/Chol 2/1 and 5 mol percent of PEG-lipid de-
rivatives (PDP-PEG-PE and mPEG-PE), were pre-
pared by the extrusion technique through 100 nm
¢lters and had an average size of 130 þ 5 nm with a
P of 0.084 þ 0.004, in accordance with previous re-
sults [4].
In order to prepare SIL, two di¡erent methods
were used to conjugate My10 mAb to the PEG chain
terminus through a cleavable disul¢de bridge as de-
scribed in Section 2 (SPDP method). In Method 1,
SPDP-activated mAb was coupled to thiolated lipo-
somes, similar to the method described previously
when using SMPB reagent (SMPB method) [4,5].
Method 2, as in conventional immunoliposome prep-
aration [13], involved the coupling of thiolated mAb
to pyridyldithio groups linked to the end of the PEG
chains. Both conjugation strategies were equally ef-
fective and resulted in a comparable number of
My10 mAb molecules per vesicle (Table 1).
The amount of mAbs bound per vesicle depends
mainly on three factors, as is the case for other co-
valent coupling methods used to prepare SIL: (1) the
Table 2
Coupling e⁄ciency and mAb density in liposomes containing PDP-PEG-PE
Mol percent PDP-PEG-PE PDP/mAb molar ratio mAb density (mAb/liposome) Coupling e⁄ciency (%)
1 15 12 þ 3 10 þ 3
1 30 12 þ 2 21 þ 2
1 70 10 þ 1 45 þ 10
1 140 5 þ 1 41 þ 6
2 15 70 þ 7 33 þ 3
2 30 56 þ 4 50 þ 5
2 70 30 þ 3 69 þ 4
2 140 13 þ 2 60 þ 2
5 30 96 þ 9 34 þ 6
5 70 65 þ 11 56 þ 6
5 140 32 þ 5 55 þ 1
0a 0 2 þ 1 1 þ 1
Liposomes were composed of a PC/Chol 2/1 molar ratio and contained 5 mol percent total PEG derivatives, consisting of a combina-
tion of mPEG(2000)-PE and PDP-PEG(3400)-PE as indicated. The coupling procedure used was the SPDP-1 and it was described in
detail in the text. The coupling e⁄ciency is expressed as the percent of initial mAb attached to the liposomes. Means þ S.D., n = 3.
aIt was calculated using the largest amount of mAb added
Table 1
E¡ect of the coupling method on mAb binding to liposomes
Method PDP/mAb molar ratio mAb density (mAb/liposome) Coupling e⁄ciency (%)
SPDP-1 70 10 þ 1 45 þ 6
SPDP-2 70 11 þ 2 50 þ 10
Liposomes were composed of a PC/Chol 2/1 molar ratio and contained 4 and 1 mol percent of PEG-PE and PDP-PEG-PE, respec-
tively. The coupling procedures are described in detail in the text. The coupling e⁄ciency is expressed as the percent of initial mAb at-
tached to the liposomes. Means þ S.D., n = 3.
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mol percent of the linker lipid incorporated into the
liposomes, (2) the mAb concentration and (3) the
PDP/mAb concentration ratio in the incubation mix-
ture [4^6,13,23]. Table 2 shows the optimization of
coupling e⁄ciency and liposomal mAb density ob-
tained in varying incubation conditions. As described
previously [4,5], the number of mAb bound to lipo-
some increases with the increase in reactive groups
on the liposome surface and with the increase in the
amount of mAb added. Di¡erent mAb surface den-
sities can be obtained from 5 to 100 mAb/vesicle and
nonspeci¢c binding of protein to the liposomes was
not observed (Table 2).
The coupling e⁄ciency increases as the mAb/PDP
molar ratio increases, reaching a maximum e⁄ciency
(70%) at ratios of 70 which represents a 70-fold ex-
cess of PDP groups. A similar behavior has been
obtained when using the SMPB method [4], but the
coupling of My10 mAb to liposomes by the latter
method was more e⁄cient due to the higher reactiv-
ity of the maleimido group (coupling e⁄ciencies were
near 100%), in line with those described in the bib-
liography [6]. Moreover, in contrast to the SMPB
method [4,5], the coupling e⁄ciency obtained by
SPDP method was dependent on the percentage of
linker lipid in the liposomes (Table 2), obtaining a
maximum e⁄ciency at 2 mol percent of PDP-PEG-
PE incorporated. On the other hand, the decrease in
the coupling e⁄ciency observed in the case of the 5
mol percent of PDP-PEG-PE supports the previously
suggested hypothesis [4] that the interference of PEG
chains with the access of mAb to its coupling site
could be decreased by using a functionalized PEG
derivative longer than an inert PEG derivative in
the brush conformation.
The presence of My10 mAb on the liposome sur-
face did not signi¢cantly change their physicochem-
ical parameters as vesicle size and liposome perme-
ability. The size of SIL (13, 30 and 70 mAb/vesicle)
was found to be 135 þ 12, 133 þ 10 nm and 140 þ 15
(P6 0.2), respectively. The CF leakage of prepared
SIL at 37‡C for 2 h was less than 3% (data not
shown).
3.2. Antigen binding activity
The preservation of antigen-binding activity of the
My10-SIL was corroborated by £ow cytometry (Fig.
1) and by £uorescence confocal microscopy (data not
shown). The binding was evaluated by using My10-
Fig. 1. (A) Cyto£uorimetric determination of My10-SIL (200 WM TL, 10 mAb/liposome) binding to KG-1a cells prepared by methods
SPDP-1 and SPDP-2 from the experiments shown in Table 1. (B) Cyto£uorimetric determination of My10-SIL (13 mAb/liposome)
binding to hematopoietic CD34+ cells at two lipid concentrations. SIL entrapping CF and prepared by SPDP-1 method were incu-
bated with cells (106 cell/ ml) for 30 min at 4‡C and rinsed twice with PBA. The non-speci¢c £uorescence binding was measured incu-
bating cells with 200 WM TL of bare SL or IgG1-SIL (12 mAb/liposome) entrapping CF. The x-axis represents the logarithm of green
£uorescence signal, and the y-axis represents cell count.
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SIL containing CF as an aqueous marker after incu-
bation with cells at 4‡C, in order to inhibit the en-
docytosis process. Both methods of My10-SIL prep-
aration produced similar results. The SIL prepared
by Method 1 presented a similar binding to
CD34+KG-1a cells, expressed as mean £uorescence
intensity (MFI), as that presented by the SIL pre-
pared by Method 2, with the same number of
mAb/vesicle (Fig. 1A). In these conditions, it was
estimated that an average of 4450 þ 500 liposomes
were bound per cell, calculated on the basis of the
Rho-PE £uorescence associated to cells. Also, these
results indicated that the blockage process of the free
thiol groups with acetamide did not a¡ect the anti-
gen binding activity of SIL. The degree of SIL bind-
ing per cell was related to the degree of antigen ex-
pression on the cells. As can be seen in Fig. 1B, the
My10-SIL were bound to puri¢ed CD34+ hemato-
poietic progenitor cells (s 95% of CD34+ cells), but
this binding was minor to KG-1a cells due to their
low level of antigen expression.
To determine the speci¢city of the My10-SIL to-
ward CD34+ cells, negative control binding experi-
ments were performed using isotype-matched control
liposomes (IgG1-SIL) (Fig. 1A) and liposomes with-
out mAb (data not shown). These negative control
incubations resulted in very low binding values to
CD34+KG-1a cells and it was independent of the
nature of the reactive group on the liposome surface
(methoxy, PDP or acetamide), in accordance with
previous results [4]. In addition, My10-SIL did not
bind signi¢cantly to CHO or Jurkat cells, which do
not express CD34 antigen as con¢rmed by £ow cy-
tometry (data not shown). The MFI obtained was in
Table 3
MFI and percentage of the subpopulations of CD34+ KG-1a cells in mixtures with CD34- cells
CD343
cells
Initial percent of
CD34+ cells
Lipid concentration
(WM)
HPCA-2 My10+GAM-FITC My10-SIL
MFI (%) MFI (%) MFI (%)
Jurkat 2.5 100 18.5 þ 2.3 2.2 þ 0.2 n.d. n.d. 5.8 þ 0.8 2.2 þ 0.1
CHO 2.5 100 17.6 þ 2.0 2.3 þ 0.1 57.6 þ 3.0 2.2 þ 0.1 6.0 þ 0.6 2.3 þ 0.3
CHO 2.5 200 17.6 þ 2.0 2.3 þ 0.1 57.6 þ 3.0 2.2 þ 0.1 42.5 þ 3.0 2.5 þ 0.2
CHO 4.5 200 17.8 þ 1.8 4.7 þ 0.2 47.3 þ 4.1 4.2 þ 0.2 38.5 þ 3.2 4.1 þ 0.3
Cell mixtures of KG-1a CD34+ cells and CD34- cells (CHO or Jurkat) were treated by direct immunostaining assay with My10-SIL
(10 mAb/vesicle and prepared by SPDP-1 method) entrapping CF or with the HPCA-2 mAb labelled with FITC and by indirect im-
munoassay with the mAb My10 and the secondary Ab GAM-FITC. Samples were analyzed by £ow cytometry and the results are ex-
pressed as the MFI and the percentage of CD34+ cells. Means þ S.D., n = 3.
Fig. 2. (A) E¡ect of the lipid concentration on the degree of
SIL binding to KG-1a. My10-SIL (13 mAb/vesicle) prepared by
the SPDP-1 method and entrapping CF were incubated for 30
min at 4‡C with KG-1a cells (106 cells/ml) and analyzed by
£ow cytometry. (B) E¡ect of the mAb density on the SIL bind-
ing. My10-SIL (200 WM TL) prepared by SPDP-1 method and
containing di¡erent amounts of mAb/vesicle were incubated
with cells (106 cells/ml) for 30 min at 4‡C. Samples were ana-
lyzed by £ow cytometry as described previously using bare SL
entrapping CF as negative control. The experiments were re-
peated three times, with S.D.6 8%.
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the same order as that obtained by liposomes with-
out mAb.
The degree of SIL binding to cells at 4‡C depends
on the liposome concentration and on the mAb den-
sity at the liposome surface (Fig. 2). As the concen-
tration of the added SIL was increased (at a constant
cell concentration), the number of liposomes bound
per cell increased, having a saturation tendency (Fig.
2A). Similar behavior was observed when increasing
the liposomal mAb density to more than 80 mAb/
vesicle (Fig. 2B). These results are in accordance with
previous studies [4^6,24]. The modest increase in the
amount of SIL binding obtained with hematopoietic
progenitor cells (low level of CD34 expression), by
increasing liposome concentration (Fig. 1B), demon-
strates that the saturation level of SIL binding is
dependent on the degree of CD34 expression.
3.3. Speci¢city of targeting in cell mixtures
The use of immunoliposomes to increase the sen-
sitivity of the analysis and the sorting of cells by
immuno£uorescence according to speci¢c marker
molecules has been proposed elsewhere [12,25]. The-
oretically, antibodies conjugated to £uorochrome-
¢lled liposomes have a much higher sensitivity of
Fig. 3. Release of bound SIL from CD34+KG-1a cells. (A) Fluorescence histograms of KG-1a cells with My10-SIL bound after treat-
ment with 50 mM DTT for 30 min at three di¡erent temperatures (solid lines). SIL (200 WM TL, 13 mAb/liposome) prepared by the
SPDP-1 method and entrapping CF were incubated with cells (106 cells/ ml) for 30 min at 4‡C and rinsed twice with PBA (dotted
line). The non-speci¢c £uorescence binding was measured incubating cells with bare SL entrapping CF (dotted line). The x-axis repre-
sents the logarithm of green £uorescence signal, and the y-axis represents cell count. (B) Percentage of positive cells after di¡erent
treatments with DTT at 4‡C (¢lled bars), at 20‡C (open bars) and at 37‡C (dashed bars). As a negative control, cells incubated with
bare SL entrapping CF under the same conditions were used. The experiments were repeated three times, with S.D.6 10%.
Table 4
Stability of vesicle disul¢de linkage in presence of culture medium (10% of FCS) at 37‡C
Time (h) 0 2 6 9 24
PDP-PEG-PE (%) 4.8 þ 0.1 4.8 þ 0.2 4.8 þ 0.2 4.8 þ 0.1 4.2 þ 0.1
Liposomes composed of PC/Chol 2/1 molar ratio and containing 5 mol percent of PDP-PEG-PE were incubated at 37‡C during di¡er-
ent times in RPMI-1640 medium (10% of FCS). The intact disul¢de linkage remaining at the liposome surface (pyridyldithio groups,
PDP) was calculated by the 100% release of 2-thiopyridone from liposomes following reduction of PDP groups with DTT as deter-
mined spectrophotometrically following separation of vesicles on gel ¢ltration over Sephadex G-50 spin columns. Means þ S.D., n = 3.
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detection than single labelled antibodies since one
liposome can contain a large number of £uoro-
chrome molecules. Given that CD34+ cells are only
present at low percentage (1^4%) in clinical samples
(as cord blood, mobilized peripheral blood and bone
marrow) and in order to develop criteria for the pos-
sible future clinical applications of anti-CD34 SIL,
we tested the determination by £ow cytometry of
the percentage of CD34+KG-1a cells in mixtures
with CHO or Jurkat CD34- cells by direct labelling
using My10-SIL entrapping CF. Direct labelling with
the anti-CD34 HPCA2-FITC mAb or by indirect
labelling with My10 mAb and a secondary antibody
GAM-FITC served as an internal control for specif-
icity and sensitivity. MFI values and percentage of
the subpopulations of CD34+KG-1a cells are sum-
marized in Table 3. Direct immunostaining with
My10-SIL (100 WM TL) is su⁄cient to separate pop-
ulations of positive and negative cells optically ac-
cording to green £uorescence (data not shown),
although the MFI of the positive cells was smaller
than that obtained with HPCA2 mAb (Table 3).
Fig. 5. Analysis by confocal microscopy of KG-1a cells incubated with labelled anti-CD34-SIL. (A) Cross sections through the middle
of the cells incubated with CF-SIL (200 WM) during 1 h at 20‡C. (B) Cross-sections through the middle of the cells as in (A) after
treatment with 50 mM DTT during 1 h at 20‡C and (C) bright ¢eld image of the cells as in (B). SIL entrapping CF (30 mAb/vesicle)
were incubated with KG-1a cells (5U105 cells) during 1 h at 20‡C. Unbound immunoliposomes were separated from cells by centrifu-
gation (1500 rpm, 5 min). The pellet cells were washed three times with cold PBA. Confocal microscopy was performed on a Leica
TCS 4D (Leica Lasertechnik, Heidelberg, GmbH, Germany) confocal scanning laser microscope adapted to an inverted Leitz
DMIRBE microscope. The light source was an Argon krypton laser. Green £uorescence was excited at 488 nm. The conditions in-
cluded a PL Fluotar 100U/1.30 inversion oil objective. Images of 512U512 pixels were stored on a erasable magneto optical disk and
then printed on a Mitsubishi CP2000E high resolution color printer. The photographs revealed that the SIL were present only on the
cell surface, which is in accordance with the examination of optical cross-section through the middle of the cells (A). Subsequent incu-
bation with 50 mM DTT for 1 h at 20‡C, which reduces the disul¢de bridges, removed the cell-associated £uorescence (B).
Fig. 4. Release of the KG-1a cell-associated £uorescence by the
treatment of the cells with DTT. The cells (106 cells/ml) were
incubated with 200 WM of TL of SL or SIL (13 mAb/liposome
and prepared by the SPDP-1 method) entrapping CF, 30 min
at 4‡C and rinsed twice with PBA (open bars). Afterwards, the
cells were treated with 50 mM DTT during 1 h at 20‡C (¢lled
bars). The cell-associated £uorescence was measured on a Kon-
tron SF25 spectro£uorimeter at excitation of 492 nm and emis-
sion of 520 nm wavelength. Means þ S.D., n = 3.
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Moreover, as the binding of SIL to cells increases
with the liposomal concentration added (Fig. 2A),
the sensitivity of this system can be raised by increas-
ing lipidic concentration. Independently of the initial
percentage of CD34+ cells and increasing the lipo-
somal concentration to 200 WM TL, we obtained two
populations of cells well de¢ned with a threefold in-
crease in the MFI of positive cells compared to direct
immunostaining with HPCA2 mAb and with a sim-
ilar MFI to that obtained by indirect immunostain-
ing with My10 mAb and GAM-FITC (Table 3). Fur-
thermore, in the latter case, quantitative separation
of positive from negative cells using My10-SIL was
obtained with a lower concentration of My10 mAb
(1.3 Wg/ml with My10-SIL versus 2 Wg/ml with My10
mAb and GAM-FITC) besides a minor manipula-
tion of the sample.
3.4. Cleavage of cell bound SIL and CD34+ cell
viability
The disul¢de exchange reaction used here for
mAb^liposome conjugation is not stable under in
vivo conditions because of the susceptibility of the
disul¢de linkage to reduction by serum components
such as glutathione [26]. For ex vivo conditions, the
mAb^vesicle disul¢de linkage was quite stable (Table
4). For example, a percentage higher than 87.5% of
the original linkage remained stable during 24 h of
incubation in the cell culture medium (10% of FCS),
as described elsewhere [26].
Previous studies have shown that cells can be re-
leased from synthetic supports by simple exposure to
DTT under mild conditions and also this process
does not a¡ect the cell capacity to form colonies
[16]. In our case, one would expect the My10-SIL
entrapping CF to be released during the incubation
with DTT as reducing agent. Fig. 3A shows the re-
sults of the experiment with 50 mM DTT at three
temperatures during 30 min of incubation. The re-
duction in cell £uorescence is not due to the natural
dissociation of the SIL related to antigen^antibody
equilibrium as shown by the retention of £uorescence
in the absence of DTT at the three temperatures
assayed (data not shown). Neither is the decrease
in the cell-£uorescence related to the leakage of en-
trapped dye, since incubation of SIL with DTT does
not damage the vesicle membrane (data not shown),
in line with previous results [26]. Analyses of a range
of conditions for the release of SIL from the cells are
shown in Fig. 3B. SIL are released at 37‡C after 30
min of incubation with 50 mM DTT, whereas 1 h
was needed with 20 mM DTT. The release is negli-
gible at 4‡C while at 20‡C, 1 h of incubation was
needed with 50 mM DTT.
Fig. 6. Flow cytometry biparametric dot plots showing viable
KG-1a cells based on FDA positive cells (green £uorescence)
and PI negative cells (red £uorescence) after 24 h of incubation
at 37‡C. (A) Untreated KG-1a cells (control). (B) Cells incu-
bated with SIL (13 mAb/liposome and prepared by SPDP-1
method) for 1 h at 20‡C and, after this time, the SIL bound to
cells were released by treatment with 50 mM DTT at 20‡C dur-
ing 1 h. Regarding FDA+/PI- staining, neither, untreated KG-
1a cells nor SIL+DTT treated cells showed a decreased viabil-
ity.
BBAMEM 77962 5-12-00
M. Mercadal et al. / Biochimica et Biophysica Acta 1509 (2000) 299^310308
The results obtained were con¢rmed by spectro-
£uorimetry and by confocal £uorescence microscopy.
The cell-associated £uorescence, after incubation
with SIL, was removed by treatment with 50 mM
DTT at 20‡C for 1 h, reaching the same £uorescence
levels as cells incubated with bare SL (Fig. 4). The
photographs of confocal microscopy revealed that
the £uorescence associated with cell surface by incu-
bation with SIL at 4 or 20‡C during 1 h could be
eliminated by incubation with DTT (Fig. 5). The loss
of £uorescence was not associated with a CF leak-
age, due to the treatment with the reducing reagent,
because when SIL, with a thioether linkage between
mAb and liposome were used, no loss of £uorescence
was observed [4].
In order to use the SIL as cell markers for prac-
tical purposes, it was ¢rst necessary to demonstrate
that the interaction between liposomal and cellular
membranes did not in£uence the cell viability. KG-
1a cells were incubated with SIL for 1 h at 20‡C and,
after this time, the SIL bound to cells were released
by treatment with 50 mM DTT at 20‡C for 1 h. Cell
viability was determined by £ow cytometry after 24 h
of incubation in culture medium. The cell mortality
for treated cells was equal to that for control cells,
but always less than 3% (Fig. 6).
4. Concluding remarks
Over the last few years a number of advances have
been made in the development of methodologies for
the preparation of SIL. Now, with a number of use-
ful reagents in our repertoire, it is possible to achieve
reasonable mAb densities on liposomal surfaces,
while sacri¢cing very few of the bene¢cial properties
of PEG-liposomes. In order to exploit the potential
of immunoliposomal systems to the full, this report
examines an established method for coupling anti-
CD34 My10 mAb to PEG-liposomes containing the
anchor PDP-PEG-PE via a cleavable disul¢de bond.
The amount of protein bound to the vesicles can be
controlled by varying the mAb and/or varying lipid
concentrations in the coupling mixture. Di¡erent
mAb surface densities can be obtained from 5 to
100 mAb/vesicle with a maximum coupling e⁄ciency
of 70% working at mAb/PDP molar ratios of 70 and
at 2 mol percent of PDP-PEG-PE conditions. The
antigen-binding activity of the conjugates was well
preserved and the My10-SIL bound speci¢cally to
CD34+ (KG-1a and hematopoietic progenitor cells).
The degree of SIL binding to CD34+ cells depends
on the liposome concentration, on the mAb density
in the liposome surface and on the CD34 cell expres-
sion. Direct immunostaining with My10-SIL allowed
determination by £ow cytometry CD34+ KG-1a cells
at percentages similar to those found in clinical sam-
ples in mixtures of KG-1a cells with CD34- cells
(CHO or Jurkat). Quantitative separation of positive
from negative cells using My10-SIL was obtained for
at lower concentration of mAb compared to indirect
immunostaining and with a threefold increase in the
MFI of positive cells compared to direct immuno-
staining with HPCA2 mAb. For ex vivo conditions,
the mAb^vesicle disul¢de linkage was quite stable
and the liposomes can be released from cells by sim-
ple exposure to DTT as reducing agent under mild
conditions (1 h of incubation with 50 mM DTT at
20‡C). The ability to remove attached vesicles repre-
sents an advantage in in vitro experiments designed
to study the cellular uptake of liposomes, as it was
pointed out previously with conventional immunoli-
posomes [26]. After SIL binding and subsequent
DTT treatment, the cell viability was guaranteed.
One future objective would be the characterization
and optimization of My10-SIL binding to CD34+
hematopoietic progenitor cells in order to develop
criteria for the possible clinical applications of anti-
CD34 SIL. With this aim, the preparation of My10-
SIL loaded with CF and magnetic beads could be
used as staining reagent for analysis and sorting cells
with low expression of target antigen (such as CD34
antigen in hematopoietic stem cells), as described in
other systems [12]. Moreover, the phospholipid coat-
ing of SIL makes the magnetic separation vehicles
more biological than other immunomagnetic systems
as magnetic microspheres or dextran-magnetite par-
ticles.
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